Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-939-6 | CAS number: 68921-42-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Effects on fertility
Description of key information
Reproductive toxicity study
Based on the data available from different studies, NOAEL for test material was considered to be 1000mg/kg /day for reproductive toxicity, when male and female rats were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Link to relevant study records
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data from various test chemicals
- Justification for type of information:
- Weight of evidence approach based on the available information from various test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on reproductive toxicity studies on rats
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data available
- Species:
- rat
- Strain:
- other: 1.Charles River CD 2.Long-Evans
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 1.TEST ANIMALS
- Weight at study initiation: 601 G (Male/female) and 487 G (Female)
Age at study initiation: 38 days old at initation of F0 phase
- Source: Charles River Breeding Laboratories, Portage, MI
- Housing: housed individually in hanging wire mesh cages
- Diet (e.g. ad libitum): Purina Laboratory Rodent Chow No. 5001 (Ralston Purina Company, Inc., St Louis, MO) ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-21°C
- Humidity (%):40-60%
- Photoperiod (hrs dark / hrs light): 12-hr light/dark cycleTEST ANIMALS - Route of administration:
- oral: feed
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- other: diet(Purina Laboratory Rodent Chow No. 5001 (Ralston Purina Company, Inc., St Louis, MO))
- Details on exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): weekly during the first 13 wk of study, and then monthly thereafter.
- Mixing appropriate amounts with (Type of food): Purina Laboratory Rodent Chow No. 5001 (Ralston
Purina Company, Inc., St Louis, MO) blended in a twin-shell blender
- Storage temperature of food: 20-21°C - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation:no data
- After successful mating each pregnant female was caged (how): housed in plastic boxes with ground corncob bedding. - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- Analyses of compound concentration were conducted weekly during the first 13 wk of study, and then monthly thereafter. Analyses of the basal feed for heavy metals, chlorinated hydrocarbons, and aflatoxin were conducted on all lots of feed used during the study. These analyses demonstrated that the basal feed contained acceptably low levels of contaminants, that the diets were prepared properly, and that the dietary content of the test material was stable.
- Duration of treatment / exposure:
- 1.The maximum exposure times were 116 and 111 wk for males and females, respectively.
2.80-day ( 2 weeks before the first mating, and dosing continued throughout the gestation, lactation, and post-weaning phases for three successive generations.) - Frequency of treatment:
- daily
- Details on study schedule:
- No data available
- Remarks:
- Study 1
Doses / Concentrations:
0, 0.1, 1.0, 2.0 % in the diet (0,50,500,1000 mg/kg bw /day respectively)
Study 2
0, 10, 100, 300, or 1,000 mg/kg b.w./day. - No. of animals per sex per dose:
- Study 1
60 males + 60 females F0; 70 males + 70 females F1
Study 2
Total:300
F0 generation
0 mg/kg bw/day:10male and 20 females
10mg/kg bw/day:10male and 20 females
100mg/kg bw/day:10male and 20 females
300 mg/kg bw/day:10male and 20 females
1000mg/kg bw/day: 10male and 20 females
F1 generation
0 mg/kg bw/day:10male and 20 females
10mg/kg bw/day:10male and 20 females
100mg/kg bw/day:10male and 20 females
300 mg/kg bw/day:10male and 20 females
1000mg/kg bw/day: 10male and 20 females - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data available
- Positive control:
- No data available
- Parental animals: Observations and examinations:
- DETAILED CLINICAL AND MORTALITY OBSERVATIONS: Yes
- Time schedule: twice daily with at least 5 hr between observations.
BODY WEIGHT: Yes
- Time schedule for examinations: weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):Yes
- Time schedule for examinations: Weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: 3, 6, 12, 18 and 24 months of the chronic phase
HAEMATOLOGY: Yes
- Time schedule for collection of blood:
- Animals fasted: No data
- How many animals: Ten animals of each sex from each group
- Parameters checked: haemoglobin, haematocrit, erythrocyte and total and differential leucocyte counts, and erythrocyte morphology
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: 3, 6, 12, 18 and 24 months of the chronic phase and at the end of the study.
- Animals fasted: No data
- How many animals: Ten animals of each sex from each group
-Parameters checked: aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, blood urea nitrogen, fasting glucose, total protein and creatinine
URINALYSIS: Yes
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
-Parameters checked: gross and microscopic appearance, specific gravity, pH and for the presence of protein, glucose, ketones, bilirubin and occult blood
OTHER:
Detailed physical examinations for signs of toxicity and palpation for masses: YES,
- Time schedule for examinations: weekly.
ORGAN WEIGHT:
- How many animals: Organ weights were measured in ten rats/sex/group
-Organ examined - brain, gonads, kidneys, liver, spleen and thyroid. - Oestrous cyclicity (parental animals):
- No data available
- Sperm parameters (parental animals):
- No data available
- Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities.
GROSS EXAMINATION OF DEAD PUPS: Yes,external and internal abnormalities - Postmortem examinations (parental animals):
- SACRIFICE :Yes
GROSS NECROPSY: yes
HISTOPATHOLOGY / ORGAN WEIGHTS:yes,histopathological examination of ovaries.gonads weight, histopathological examination of testes with epididymides - Postmortem examinations (offspring):
- No data available
- Statistics:
- The one-way ANOVA was applied using the F distribution to assess significance. If significant differences among the means were indicated, Dunnett's test was used to determine which means were significantly different from control (Dunnett, 1964). If a non-parametric procedure for testing equality of means was indicated, the Kruskal-Wallis test was used (Hollander and Wolfe, 1973). If differences from the controls were indicated, a summed rank test was used to determine which groups differed from the controls.
- Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- 1.Blue staining of hair , exposed skin and faeces was noted in all treatment group, other physical observations noted at low incidence in both control and treated rats included rales, red material around the eyes ,nose or anogenital region, redness around the eyes, white areas in the internal eyes corneal opacities , dilated pupils and increased distance between the pupil and cornea .Palpable masses primarily in the abdominal, thoracic and anogenital regions were present at similar incidence in control and treated rats.
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- one female in the 1.0% group and one male and one female in the 1.0% group and one male in the 2.0% group died. These deaths were not related to treatment.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Group mean body weight at the end of the study were generally similar for control and treated male and female rats with the exception of the females in the 2.0% group.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Food consumption was slightly greater for males and females in the 2.0% group. These differences were statistically significant (P<0.05) for males between wk 27and 66and for female between wk 27 and 38 and between wk 79 and 90
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Ophthalmoscopic examinations at most examination intervals revealed chorioretinal degeneration and choroidal and choriorentinal hypoplasia in both control and treated rats . Conjunctivitis and keratitis were the most common finding and were seen in similar or greater numbers of control rats than of treated rats. None of these findings were compound related .
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- Few of the heametological parameters showed significant difference between control and treated animals and none of the difference appeared to be compound related
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- Few of the clinical chemistry parameters showed significant difference between control and treated animals and none of the difference appeared to be compound related
- Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- Few of the urinalysis parameters showed significant difference between control and treated animals and none of the difference appeared to be compound related
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- The complete gross autopsies were also performed on all animals that died on test or that were killed at the end of the study. Histological evaluation revealed a variety of lesions including neoplasms among control and treated rats , These lesions were present in similar incidence in control and treated rats and appeared to be spontaneous , None of the lesions were determined to be related to the administration of test material.
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- 1.There were no compound related effects on fertility, gestation, parturition , lactation , pup survival through weaning or on number of live and stillborn pups.
2.No effects attributable to treatment were observed with respect to mating performance,pregnancy and fertility rates, gestation length. - Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- ophthalmological examination
- haematology
- clinical biochemistry
- urinalysis
- organ weights and organ / body weight ratios
- gross pathology
- reproductive performance
- Remarks on result:
- other: overall toxic effects on reproductive parameters
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: effects: no substance-related effects on fertility, gestation, parturition, lactation, pup survival through weaning, or on the numbers of live and stillborn pups.
- Remarks on result:
- other: No effect observed.
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Generation:
- other: F3a
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- organ weights and organ / body weight ratios
- gross pathology
- Remarks on result:
- other: No developmental toxic effects were observed
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Conclusions:
- “No observed adverse effect level (NOAEL)” for reproductive toxicity was considered to be 2.0 % (1000 mg/kg bw /day).When Charles River CD rats were treated with test chemical orally.
- Executive summary:
Data available from different studies were reviewed to determine the reproductive toxicity of testchemical.The studies are as mentioned below:
Study 1
The test chemical was fed to Charles River CD rats as a dietary admixture in lifetime toxicity/carcinogenicity studies. The rat study was conducted with an in utero phase in which the compound was administered to the F0 generation rats (60/sex/group) at dietary concentrations of 0.0%, 0.0%, 0.1%, 1.0% or 2.0%.(0, 50,500,1000 mg/kg bw /day respectively). After randomly selecting the F1 animals, the lifetime phase was initiated at the same levels with 70 rats/sex/group, including two control groups. The maximum exposure times were 116 and 111week for male and females respectively. The rats were approximately 38 days old at initiation of the F0 phase .The diet were prepared weekly during the first 13 wk of study, and then monthly thereafter and stored at 20-21°C.Animals after successful mating each pregnant female was housed in plastic boxes with ground corncob bedding. All animals were observed for clinical signs twice daily with at least 5 hr between observations. Body weight observed weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter and food consumption was noted on Weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter. Ophthalmoscopic examination noted on 3, 6, 12, 18 and 24 months of the chronic phase. Organ weights were measured in ten rats/sex/group and organ examined were brain, gonads, kidneys, liver, spleen and thyroid. In urine analysis gross and microscopic appearance, specific gravity, pH and for the presence of protein, glucose, ketones, bilirubin and occult blood were noted. Haematological parameter like haemoglobin, haematocrit, erythrocyte and total and differential leucocyte counts, and erythrocyte morphology were observed.
Clinical signs like Blue staining of hair , exposed skin and faeces was noted in all treatment group, other physical observations noted at low incidence in both control and treated rats included rales, red material around the eyes ,nose or anogenital region, redness around the eyes, white areas in the internal eyes corneal opacities , dilated pupils and increased distance between the pupil and cornea .Palpable masses primarily in the abdominal, thoracic and anogenital regions were present at similar incidence in control and treated rats.Group mean body weight at the end of the study were generally similar for control and treated male and female rats with the exception of the females in the 2.0% group. Food consumption was slightly greater for males and females in the 2.0% group. These differences were statistically significant (P<0.05) for males between wk 27and 66and for female between wk 27 and 38 and between wk 79 and 90.No compound related gross changes, including organ weight effects were noted.Few of the heametological , clinical chemistry and urinalysis parameters showed significant difference between control and treated animals and none of the difference appeared to be compound related.Completed gross autopsies and histological evolution of the ten rats per sex from each group that were killed after 1 year revealed no compound related gross or histological changes. Complete gross autopsies were also performed on all animals that died on test or that were killed at the end of the study. Histological evaluation revealed a variety of lesions including neoplasms among control and treated rats, these lesions were present in similar incidence in control and treated rats and appeared to be spontaneous, none of the lesions were determined to be related to the administration of test material.One female in the 1.0% group and one male and one female in the 1.0% group and one male in the 2.0% group died. These deaths were not related to treatment. Ophthalmoscopic examinations at most examination intervals revealed chorioretinal degeneration and choroidal and choriorentinal hypoplasia in both control and treated rats . Conjunctivitis and keratitis were the most common finding and were seen in similar or greater numbers of control rats than of treated rats. None of these findings were compound related.There were no compound related effects on fertility, gestation, parturition, lactation, pup survival through weaning or on number of live and stillborn pups. Hence the “No observed adverse effect level (NOAEL)” for reproductive toxicity was considered to be 2.0 % (1000 mg/kg bw /day).When Charles River CD rats were treated with test chemical orally.
Study 2
Ina 3-generation reproduction study was carried out on test chemical in male and female Long-Evans rats . The test material mixed with feed and administered at dose levels of 0, 10, 100, 300, or 1,000 mg/kg b.w./day. The first generation parents (10 males, 20 females) were given the appropriate dose of test material in the diet 2 weeks before the first mating, and dosing continued throughout the gestation, lactation, and post-weaning phases for three successive generations. The F0 generation rats were mated twice, the F1a litters being necropsied at weaning, and selected animals (10 males, 20 females) from the F1b litters were used for breeding.Following an 80-day growth period, animals from the F1b generation were mated 3 times and the offspring of the F2a and F2b generations were treated identically to the F1a and F1b generations.Following the third mating, half of the pregnant dams were sacrificed on day 19 of gestation, the uterine contents were examined for total embryos/resorption sites, and the corpora lutea per ovary were recorded. The other half were allowed to deliver normally (F2c) and were sacrificed at weaning. The F2b animals were mated once and allowed to raise their offspring to weaning when both parents and offspring were culled.
Gross necropsies were performed on all parent animals and on F1a, F2a, F2c, and F3a offspring at weaning. Selected tissues from 5 animals of each sex/dose from the F1b parents and the F3a generation at weaning were fixed at necropsy, and the following tissues examined histologically from the control and high-dose group: stomach, ileum, jejunum, colon, liver, spleen, heart, lungs, adrenals, kidneys, urinary bladder, thyroid, ovaries, and uterus or testes. No effects attributable to treatment were observed with respect to food consumption, body weight, adult mortality, mating performance, pregnancy and fertility rates, gestation length, offspring survival, weights and sex, litter survival, resorption rates, or necropsy findings. There were no macroscopic or microscopic tissue abnormalities of either F1b- or F3a-generation animals considered to be attributable to treatment. Hence ,Therefore the “No observed adverse effect level (NOAEL)” for reproductive toxicity was considered to be 1000 mg/kg bw /day.Asthere were no adverse effects on food consumption, body weight, adult mortality, mating performance, pregnancy and fertility rates, gestation length, offspring survival, weights and sex, litter survival, resorptions rates, or necropsy findings were observed in rat at dose concentration 1000 mg/kg bw /day given orally.
Reference
Mean food and compound consumption of rats that received test chemical in diet throughout their lifetime
Dietary concentration of test chemical 1(%) |
Food consumption including test chemical (g/kg /day) |
Compound consumption (mg/kg/day) |
||
|
Male |
Female |
Male |
Female |
0.0 |
51 ±18 |
61±16 |
- |
- |
0.0 |
51±19 |
61±17 |
- |
- |
0.1 |
50±18 |
62±18 |
50±18 |
62±18 |
1.0 |
51±18 |
63±17 |
514±179 |
631±173 |
2.0 |
54±19 |
66±17 |
1072±381 |
1319±345 |
Survival and group mean body weights and percentage difference from control values at the end of the study of rats that recived FD&C blue no.1 in the diet throughout their lifetime (in utero )
Dietary concentration of test chemical (%) |
No. surviving at the end of the study |
Final body weight(g) |
|
|
|
Mean±SD
|
Difference from control (IA+IB) value (%) |
Male rats |
18 |
592±88 |
+0.5 |
0.0(IA) |
13 |
586±132 |
-0.5 |
0.0(IB) |
12 |
595±89 |
-1.0 |
0.1 |
12 |
601±104 |
+2.0 |
1.0 |
18 |
561±65 |
-4.7 |
2.0 |
|
|
|
Female rats |
|
|
|
0.0(IA) |
28 |
480±78 |
-2.8 |
0.0(IB) |
24 |
508±105 |
+2.8 |
0.1 |
23 |
487±102 |
-1.4 |
1.0 |
28 |
478±87 |
-3.2 |
2.0 |
10** |
420±69 |
-15.0** |
**p<0.01
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimicsh 2 and from authoritative database
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive toxicity study
Data available from different studies were reviewed to determine the reproductive toxicity of testchemical.The studies are as mentioned below:
Study 1
The test chemical was fed to Charles River CD rats as a dietary admixture in lifetime toxicity/carcinogenicity studies. The rat study was conducted with an in utero phase in which the compound was administered to the F0 generation rats (60/sex/group) at dietary concentrations of 0.0%, 0.0%, 0.1%, 1.0% or 2.0%.(0, 50,500,1000 mg/kg bw /day respectively). After randomly selecting the F1 animals, the lifetime phase was initiated at the same levels with 70 rats/sex/group, including two control groups. The maximum exposure times were 116 and 111week for male and females respectively. The rats were approximately 38 days old at initiation of the F0 phase .The diet were prepared weekly during the first 13 wk of study, and then monthly thereafter and stored at 20-21°C.Animals after successful mating each pregnant female was housed in plastic boxes with ground corncob bedding. All animals were observed for clinical signs twice daily with at least 5 hr between observations. Body weight observed weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter and food consumption was noted on Weekly for the first 14 wk, biweekly for the next 12 wk, and then every 4 wk thereafter. Ophthalmoscopic examination noted on 3, 6, 12, 18 and 24 months of the chronic phase. Organ weights were measured in ten rats/sex/group and organ examined were brain, gonads, kidneys, liver, spleen and thyroid. In urine analysis gross and microscopic appearance, specific gravity, pH and for the presence of protein, glucose, ketones, bilirubin and occult blood were noted. Haematological parameter like haemoglobin, haematocrit, erythrocyte and total and differential leucocyte counts, and erythrocyte morphology were observed.
Clinical signs like Blue staining of hair , exposed skin and faeces was noted in all treatment group, other physical observations noted at low incidence in both control and treated rats included rales, red material around the eyes ,nose or anogenital region, redness around the eyes, white areas in the internal eyes corneal opacities , dilated pupils and increased distance between the pupil and cornea .Palpable masses primarily in the abdominal, thoracic and anogenital regions were present at similar incidence in control and treated rats.Group mean body weight at the end of the study were generally similar for control and treated male and female rats with the exception of the females in the 2.0% group. Food consumption was slightly greater for males and females in the 2.0% group. These differences were statistically significant (P<0.05) for males between wk 27and 66and for female between wk 27 and 38 and between wk 79 and 90.No compound related gross changes, including organ weight effects were noted.Few of the heametological , clinical chemistry and urinalysis parameters showed significant difference between control and treated animals and none of the difference appeared to be compound related.Completed gross autopsies and histological evolution of the ten rats per sex from each group that were killed after 1 year revealed no compound related gross or histological changes. Complete gross autopsies were also performed on all animals that died on test or that were killed at the end of the study. Histological evaluation revealed a variety of lesions including neoplasms among control and treated rats, these lesions were present in similar incidence in control and treated rats and appeared to be spontaneous, none of the lesions were determined to be related to the administration of test material.One female in the 1.0% group and one male and one female in the 1.0% group and one male in the 2.0% group died. These deaths were not related to treatment. Ophthalmoscopic examinations at most examination intervals revealed chorioretinal degeneration and choroidal and choriorentinal hypoplasia in both control and treated rats . Conjunctivitis and keratitis were the most common finding and were seen in similar or greater numbers of control rats than of treated rats. None of these findings were compound related.There were no compound related effects on fertility, gestation, parturition, lactation, pup survival through weaning or on number of live and stillborn pups. Hence the “No observed adverse effect level (NOAEL)” for reproductive toxicity was considered to be 2.0 % (1000 mg/kg bw /day).When Charles River CD rats were treated with test chemical orally.
Study 2
Ina 3-generation reproduction study was carried out on test chemical in male and female Long-Evans rats . The test material mixed with feed and administered at dose levels of 0, 10, 100, 300, or 1,000 mg/kg b.w./day. The first generation parents (10 males, 20 females) were given the appropriate dose of test material in the diet 2 weeks before the first mating, and dosing continued throughout the gestation, lactation, and post-weaning phases for three successive generations. The F0 generation rats were mated twice, the F1a litters being necropsied at weaning, and selected animals (10 males, 20 females) from the F1b litters were used for breeding.Following an 80-day growth period, animals from the F1b generation were mated 3 times and the offspring of the F2a and F2b generations were treated identically to the F1a and F1b generations.Following the third mating, half of the pregnant dams were sacrificed on day 19 of gestation, the uterine contents were examined for total embryos/resorption sites, and the corpora lutea per ovary were recorded. The other half were allowed to deliver normally (F2c) and were sacrificed at weaning. The F2b animals were mated once and allowed to raise their offspring to weaning when both parents and offspring were culled.
Gross necropsies were performed on all parent animals and on F1a, F2a, F2c, and F3a offspring at weaning. Selected tissues from 5 animals of each sex/dose from the F1b parents and the F3a generation at weaning were fixed at necropsy, and the following tissues examined histologically from the control and high-dose group: stomach, ileum, jejunum, colon, liver, spleen, heart, lungs, adrenals, kidneys, urinary bladder, thyroid, ovaries, and uterus or testes. No effects attributable to treatment were observed with respect to food consumption, body weight, adult mortality, mating performance, pregnancy and fertility rates, gestation length, offspring survival, weights and sex, litter survival, resorption rates, or necropsy findings. There were no macroscopic or microscopic tissue abnormalities of either F1b- or F3a-generation animals considered to be attributable to treatment. Hence ,Therefore the “No observed adverse effect level (NOAEL)” for reproductive toxicity was considered to be 1000 mg/kg bw /day.Asthere were no adverse effects on food consumption, body weight, adult mortality, mating performance, pregnancy and fertility rates, gestation length, offspring survival, weights and sex, litter survival, resorptions rates, or necropsy findings were observed in rat at dose concentration 1000 mg/kg bw /day given orally.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.